1st Annual Treatment-Related Adverse Events Symposium: Focus on Management
In-Person Event
Oct 27, 2017
New York City, New York, USA
OVERVIEW
1st Annual Treatment-Related Adverse Events Symposium: Focus on Management is organized by Memorial Sloan Kettering Cancer Center and would be held on Oct 27, 2017 at Mortimer B. Zuckerman Research Center, New York, United States of America.
The target audience for this medical event for physicians and healthcare professionals in Breast Medical Oncology, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hematology & Oncology, Medical Oncology, Neuro-Oncology, and Palliative Medicine. This CME Conference has been approved with a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description :
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) radiation, and therapeutic transplants have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.
Conference Objectives are :
• Recognize the clinical presentation, impact on quality of life, and grading of treatment-related adverse events in cancer patients
• Understand mechanisms and interventions to prevent and treat acute and chronic adverse events in cancer patients and survivors
• Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients
Additional details will be posted as soon as they are available.
The target audience for this medical event for physicians and healthcare professionals in Breast Medical Oncology, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hematology & Oncology, Medical Oncology, Neuro-Oncology, and Palliative Medicine. This CME Conference has been approved with a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description :
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) radiation, and therapeutic transplants have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.
Conference Objectives are :
• Recognize the clinical presentation, impact on quality of life, and grading of treatment-related adverse events in cancer patients
• Understand mechanisms and interventions to prevent and treat acute and chronic adverse events in cancer patients and survivors
• Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients
Additional details will be posted as soon as they are available.
KEY DATES
27 Oct, 2017
Event Start Date
27 Oct, 2017
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Mortimer B. Zuckerman Research CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links